Experimental Schistosoma japonicum-induced pulmonary hypertension.
<h4>Background</h4>Schistosomiasis, a major cause of pulmonary arterial hypertension (PAH) worldwide, is most clearly described complicating infection by one species, Schistosoma mansoni. Controlled exposure of mice can be used to induce Type 2 inflammation-dependent S. mansoni pulmonary...
Main Authors: | Biruk Kassa, Michael H Lee, Rahul Kumar, Claudia Mickael, Linda Sanders, Rubin M Tuder, Margaret Mentink-Kane, Brian B Graham |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-04-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0010343 |
Similar Items
-
Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01) -
Th2 CD4+ T Cells Are Necessary and Sufficient for Schistosoma‐Pulmonary Hypertension
by: Rahul Kumar, et al.
Published: (2019-08-01) -
Paclitaxel blocks Th2-mediated TGF-β activation in -induced pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2018-12-01) -
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension
by: Sue Gu, et al.
Published: (2022-07-01) -
The Role of Type 2 Inflammation in Schistosoma-Induced Pulmonary Hypertension
by: Claudia S. Mickael, et al.
Published: (2019-01-01)